MedTech Acquisition Corporation
MTAC · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $354,375 | $313,438 | $308,750 | $0 |
| - Cash | $0 | $154 | $201 | $1,335 |
| + Debt | $0 | $2,372 | $544 | $0 |
| Enterprise Value | $354,375 | $315,656 | $309,093 | -$1,335 |
| Revenue | $29,431 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Gross Profit | $25,328 | $0 | $0 | – |
| % Margin | 86.1% | – | – | – |
| EBITDA | -$36,165 | -$8,583 | -$10,785 | – |
| % Margin | -122.9% | – | – | – |
| Net Income | -$33,233 | $5,539 | $4,767 | – |
| % Margin | -112.9% | – | – | – |
| EPS Diluted | -1.06 | 0.18 | 0.15 | – |
| % Growth | -688.9% | 20% | – | – |
| Operating Cash Flow | -$40,843 | -$2,737 | -$1,738 | – |
| Capital Expenditures | $0 | $0 | $0 | – |
| Free Cash Flow | -$40,843 | -$2,737 | -$1,738 | – |